Total Wealth Planning & Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.19M Sell
49,290
-3,290
-6% -$86.1K 0.8% 28
2026
Q1
$1.48M Buy
52,580
+1,650
+3% +$43.9K 1.09% 15
2025
Q4
$1.27M Buy
+50,930
New +$1.28M 0.94% 20
2025
Q2
$922K Buy
38,048
+10,189
+37% +$238K 0.75% 32
2025
Q1
$706K Buy
27,859
+2,716
+11% +$71.1K 0.67% 40
2024
Q4
$667K Buy
+25,143
New +$682K 0.61% 42

Other funds holding PFE

Total Wealth Planning & Management's PFE Position: Q2 2026 in Review

Total Wealth Planning & Management reduced its Pfizer (PFE) stake by 6.3% in Q2 2026, selling an estimated $86.1K and leaving 49,290 shares worth $1.19M. The position accounts for 0.8% of the portfolio, ranked #28.

Total Wealth Planning & Management first reported a position in PFE in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.48M in Q1 2026. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Total Wealth Planning & Management held 49,290 shares of Pfizer worth $1.19M as of Q2 2026.
  • Total Wealth Planning & Management sold 3,290 Pfizer shares in Q2 2026, an estimated $86.1K.
  • Pfizer made up 0.8% of Total Wealth Planning & Management's portfolio in Q2 2026, its #28 holding.
  • Total Wealth Planning & Management first reported a position in Pfizer in Q4 2024 and has held it in 6 quarters since.
  • Total Wealth Planning & Management's Pfizer position peaked at $1.48M in Q1 2026.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Total Wealth Planning & Management's 13F filing for Q2 2026, filed 28 Jul 2026.